Related Experiment Videos
Pancreaticoduodenectomy for benign disease
Annals of Surgery
|January 1, 1983
Summary
Pancreaticoduodenectomy (PD) for benign disease offers excellent long-term survival with low mortality. This surgical approach is supported when malignancy is suspected but uncertain, ensuring no early cancers are missed.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Hepatobiliary Surgery
Background:
- Pancreaticoduodenectomy (PD) is a complex procedure often indicated for periampullary masses.
- Benign conditions can mimic malignant presentations, leading to diagnostic uncertainty.
- Previous literature reports variable outcomes for PD in benign versus malignant cases.
Purpose of the Study:
- To evaluate the outcomes of pancreaticoduodenectomy (PD) performed for histologically benign disease.
- To assess the safety and long-term survival following PD when initially indicated for suspected malignancy.
- To provide evidence supporting surgical resection in cases of diagnostic uncertainty for periampullary masses.
Main Methods:
- Retrospective review of ten cases of PD for benign disease.
- Comprehensive literature review of PD cases for benign disease and pancreatitis complications.
- Analysis of surgical mortality and long-term patient survival.
Main Results:
- All ten patients undergoing PD for benign disease were alive and well at an average of 7.5 years post-surgery.
- Literature review identified 52 PD cases for benign disease (suspected carcinoma) with 9.6% mortality.
- PD for pancreatitis complications had a 4.8% mortality rate.
Conclusions:
- PD for benign disease demonstrates low perioperative mortality and excellent long-term survival.
- Resection is justifiable in cases of diagnostic uncertainty for periampullary masses to avoid missing resectable malignancies.
- This approach ensures favorable outcomes when the resected lesion is ultimately found to be benign.